Skip to main content
SpringerLink
Log in

Selection of cytotoxic T lymphocytes against autologous human melanoma from lymph nodes with metastatic melanoma using repeatedin vitro sensitization

  • Research Papers
  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

Our goal was to determine the cytotoxic activity of effector cells in lymph nodes with metastatic melanoma. Lymphocytes contained within tumor cells from metastatic lymph nodes of two patients were allowed to proliferate in recombinant IL-2 (rIL-2, 100-1,000 units/ml) after 14–21 days of culture. Each set of lymphocytes showed cytotoxicity against autologous melanoma (AM, mean 72%) at effector to target ratio of 20∶1 and K562 cells (mean 60%) using 4-h chromium-51 release assay. Using unlabeled AM and K562, each AM could partially block the activity against K562, but K562 could not block the activity against AM. These activated lymphocytes underwentin vitro sensitization (IVS) with irradiated AM cells and rIL-2 at 2-week intervals. After repeated IVS over about 50 days, each patient's lymphocytes showed cytotoxicity against AM (mean 54%) but not K562 (mean 5%,P < 0.001). These results indicate that different cytotoxic effector cells were present in the early and late phase of lymphocyte tumor culture. Repeated IVS resulted in the selection of specific cytotoxic T lymphocytes. Cold target inhibition assay demonstrated that melanoma cells contained common and individual AM-associated antigen in addition to K562-associated antigens.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Balch, C. M., Riley, L. B., Bae, Y. J., Salmeron, M. A., Platsoucas, C. D., von Eschenbach, A. andItoh, K., 1990, Patterns of human tumor-infiltrating lymphocytes in 120 human cancers.Archives of Surgery,124, 200–205.

    Google Scholar 

  2. Grogan, T. M., Durie, B. G. M., Lomen, C., Spier, C., Wirt, D. P., Nagle, R., Wilson, G. S., Richter, L., Vela, E., Maxey, V., McDaniel, K. andRangle, C., 1987, Delineation of a novel pre-B cell component in plasma cell myeloma: Immunochemical, immunophenotypic, genotypic, cytologic, cell culture and kinetic features.Blood 70, 932–942.

    Google Scholar 

  3. Hersey, P., Bindon, C., Edwards, A., Murray. E., Phillips, G. andMcCarthy, W. H., 1981, Induction of cytotoxic activity in human lymphocytes against autologous and allogeneic melanoma cellsin vitro by culture with interleukin-2.International journal of Cancer 28, 695–703.

    Google Scholar 

  4. Knuth, A., Danowkis, B., Oettgen, H. F. andOld, L. J., 1984, T cell-mediated cytotoxicity against autologous malignant melanoma: Analysis with interleukin 2-dependent T cell cultures.Procedings of the National Academy of Sciences, USA 81 3511–3515.

    Google Scholar 

  5. Leong, S. P. L., Wang, T. F., Grogan, T. M., Dorrance, T. L. andRichter, L. C., 1989, Generation of cytotoxic T lymphocytes from tumor-draining lymph nodes against autologous melanoma in melanoma patients.Proceedings of the American Association for Cancer Research,30(1440), 363.

    Google Scholar 

  6. Mukherji, B., Wilhelm, S. A., Guha, A. andErgin, M. T., 1986, Regulation of cellular immune response against autologous human melanoma. I. Evidence for cell mediated suppression ofin vitro cytotoxic immune response.Journal of Immunology,136(5), 1888–1892.

    Google Scholar 

  7. Mukherji, B., Wilhelm, S. A., Guha, A. andErgin, M. T., 1986, Regulation of cellular immune response against autologous human melanoma. II. Mechanism of induction and specificity of suppression.Journal of Immunology,136(5), 1893–1898.

    Google Scholar 

  8. Muul L. M., Spiess, P. J., Director, E. P. andRosenberg, S. A., 1987, Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma.Journal of Immunology,138, 989–995.

    Google Scholar 

  9. Parmiani G., Anichini, A. andFossati G., 1990, Cellular immune response against autologous human malignant melanoma: Arein vitro studies providing a framework for a more effective immunotherapy?Journal of the National Cancer Institute,82, 361–370.

    Google Scholar 

  10. Rosenberg, S. A., Spiess, P. J. andSchwarz, S., 1978,In vitro growth of murine T cells. I. Production of factors necessary for T cell growth.Journal of Immunology,12, 1946–1950.

    Google Scholar 

  11. Rosenberg, S. A., Grimm, E. A., McGrogan, M., Doyle, A., Kawasaki, E., Koths, K. andMack, D. F., 1984, Biological activity of recombinant human interleukin-2 produced inE. coli.Science,223, 1412.

    Google Scholar 

  12. Rosenberg, S. A., Lotze, M. T., Muul, L. M., Leitman, S., Chang, A. E., Ettinghausen, S. E., Matory, Y. L., Skibber, J. M., Shiloni, E., Vetto, J. T., Seipp, C. A., Simpson, C. andReichert, C. M., 1985, Special report: Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin 2 to patients with metastatic cancer.New England Journal of Medicine,313, 1485–1492.

    Google Scholar 

  13. Rosenberg, S. A., Packard, B. S., Aebersold, P. M., Saloman, D., Topallian, S. L., Toy, S. T., Simon, P., Lotze, M. T., Yang, J. C., Seipp, C. A., Simpson, C., Carter, C., Bock, S., Schwatzentruber, D., Wei, J. P. andWhite, D. E., 1988, Special report: Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma: A preliminary report.New England Journal of Medicine,319(25), 1676–1680.

    Google Scholar 

  14. Rosenberg, S. A., Aebersold, P., Cornetta, K., Kasid, A., Morgan, R. A., Moen, R., Karson, E. M., Lotze, M. T., Yang, J. C., Topalian, S. L., Merino, M. J., Culver, K., Miller, A. D., Blaese, R. M. andAnderson, W. F., 1990, Gene transfer into humans-Immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction.New England Journal of Medicine,323(9), 570–578.

    Google Scholar 

  15. Shu, S., Chou, T. andRosenberg, S. A., 1986,In vitro sensitization and expansion with viable tumor cells and interleukin-2 in the generation of specific therapeutic effector cells.Journal of Immunology,136, 3891–3898.

    Google Scholar 

  16. Slingluff, C. L., Jr, Darrow, T., Vervaert, C., Quinn-Allen, M. A. andSeigler, H. F., 1988, Human cytotoxic T cells specific for autologous melanoma cells: Successful generation from lymph node cells in seven consecutive cases.Journal of the National Cancer Institute,80(13), 1016–1026.

    Google Scholar 

  17. Topalian, S. L., Muul, L. M. andRosenberg, S. A., 1986, Growth and immunologic characteristics of lymphocytes infiltrating human tumors.Surgical Forum 37, 390–391.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, College of Medicine, University of Arizona, 85724, Tucson, AZ, USA

    Stanley P. L. Leong, Michael E. Granberry, Yuan -Ming Zhou & Ti -Fen Wang

  2. Department of Pathology, College of Medicine, University of Arizona, 85724, Tucson, AZ, USA

    Thomas M. Grogan

  3. Arizona Cancer Center, College of Medicine, University of Arizona, 85724, Tucson, AZ, USA

    Stanley P. L. Leong, Michael E. Granberry, Yuan -Ming Zhou, Ti -Fen Wang & Thomas M. Grogan

Authors
  1. Stanley P. L. Leong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael E. Granberry
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yuan -Ming Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ti -Fen Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Thomas M. Grogan
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This work was supported by Biomedical Research Support Grant of the University of Arizona (no. 2S07 RR05675-20), the Elsa U. Pardee Foundation Grant, partly by the Arizona Chronic Disease Research Commission and partly by CA23074 from the National Institutes of Health, Bethesda, 20892, U.S.A.

Recipient of the American Cancer Society Clinical Oncology Career Award, 1987–90.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leong, S.P.L., Granberry, M.E., Zhou, Y.M. et al. Selection of cytotoxic T lymphocytes against autologous human melanoma from lymph nodes with metastatic melanoma using repeatedin vitro sensitization. Clin Exp Metast 9, 301–317 (1991). https://doi.org/10.1007/BF01753732

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01753732

Keywords

Search

Navigation